Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HP INC Director's Dealing 2021

Dec 10, 2021

30213_dirs_2021-12-09_6a78e3e4-f785-4da3-8c83-e3286ef8baa2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HP INC (HPQ)
CIK: 0000047217
Period of Report: 2021-12-07

Reporting Person: Tran Tuan (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-12-07 Common Stock M 77421.00 $0.00 Acquired 171181.00 Direct
2021-12-07 Common Stock F 28568.00 $37.29 Disposed 142761.00 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-12-07 Restricted Stock Units $ A 61679.00 Acquired Common Stock (61679.00) Direct
2021-12-07 Performance Adjusted Restricted Stock Units $ A 35630.00 Acquired Common Stock (35630.00) Direct
2021-12-07 Performance Contingent Stock Options $37.29 A 163807.00 Acquired Common Stock (163807.00) Direct
2021-12-07 Restricted Stock Units $ M 31810.00 Disposed Common Stock (31810.00) Direct
2021-12-07 Restricted Stock Units $ M 31231.00 Disposed Common Stock (31231.00) Direct
2021-12-07 Restricted Stock Units $ M 14380.00 Disposed Common Stock (14380.00) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock - 401 (k) Plan 14991.23 Indirect

Footnotes

F1: Shares withheld by HP to satisfy tax withholding upon vesting.

F2: Includes 148.453 shares acquired under HP's 2021 employee stock purchase plan on 10/29/2021.

F3: Includes shares acquired and dividends earned through December 9, 2021 in the HP Inc. 401(k) Plan.

F4: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

F5: On 12/7/2021, the reporting person was granted 61,679 RSUs, one-third of which vest annually over three years on each of 12/7/2022, 12/7/2023 and 12/7/2024. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock.

F6: On 12/7/2021, the reporting person was granted 35,630 performance adjusted restricted stock units ("PARSUs"), 100% of which will only be earned after certification of financial results as of 10/31/2024, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock.

F7: The performance contingent stock options granted on 12/7/2021 will vest 33.3% on each of the first two anniversaries of the grant date, and 33.4% on the third anniversary, in each case subject to the satisfaction of certain stock price performance conditions.

F8: As previously reported, on 12/7/2020, the reporting person was granted 92,905 RSUs, 30,968 of which vested on 12/7/2021, 30,968 of which is scheduled to vest on 12/7/2022 and 30,969 of which is scheduled to vest on 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 842 vested dividend equivalent rights.

F9: As previously reported, on 12/6/2019, the reporting person was granted 87,805 RSUs, 29,268 of which vested on 12/7/2020 and 12/7/2021, and 29,269 of which is scheduled to vest on 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,963 vested dividend equivalent rights.

F10: As previously reported, on 12/7/2018, the reporting person was granted 39,250 RSUs, 13,083 of which vested on each of 12/7/2019 and 12/7/2020, and 13,084 of which vested on 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,296 vested dividend equivalent rights.